Meds Apotek Management
Management criteria checks 3/4
Meds Apotek's CEO is Björn Emil Thorngren, appointed in Jan 2017, has a tenure of 8.75 years. total yearly compensation is SEK4.33M, comprised of 63.5% salary and 36.5% bonuses, including company stock and options. directly owns 6.36% of the company’s shares, worth SEK64.39M. The average tenure of the management team and the board of directors is 7.3 years and 4.8 years respectively.
Key information
Björn Emil Thorngren
Chief executive officer
SEK 4.3m
Total compensation
| CEO salary percentage | 63.49% |
| CEO tenure | 8.8yrs |
| CEO ownership | 6.4% |
| Management average tenure | 7.3yrs |
| Board average tenure | 4.8yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | SEK 3m |
| Mar 31 2025 | n/a | n/a | -SEK 4m |
| Dec 31 2024 | SEK 4m | SEK 3m | -SEK 10m |
| Dec 31 2023 | SEK 3m | SEK 2m | -SEK 51m |
Compensation vs Market: Björn Emil's total compensation ($USD462.47K) is above average for companies of similar size in the Swedish market ($USD315.31K).
Compensation vs Earnings: Björn Emil's compensation has been consistent with company performance over the past year.
CEO
Björn Emil Thorngren (49 yo)
Mr. Björn Emil Gustaf Thorngren is the Founder of Meds Apotek AB and has been its CEO and Director since 2017. Mr. Thorngren was the Senior Analyst at Brainheart Capital. He holds a Masters degree in Busin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 8.8yrs | SEK 4.33m | 6.36% SEK 64.4m | |
| Co-founder & COO | 8.8yrs | no data | no data | |
| Chief Financial Officer | 4.8yrs | no data | no data | |
| Director of Business Development & HR | 5.8yrs | no data | no data | |
| Head of Logistics | 3.8yrs | no data | no data | |
| Chief Commercial Officer | 8.8yrs | no data | no data |
Experienced Management: MEDS's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 8.8yrs | SEK 4.33m | 6.36% SEK 64.4m | |
| Independent Director | 4.8yrs | SEK 464.79k | no data | |
| Independent Chairman of the Board | 7.8yrs | SEK 400.61k | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
Experienced Board: MEDS's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/06 03:05 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Meds Apotek AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.